Ameriprise’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-92,656
| Closed | -$82K | – | 4071 |
|
|
2022
Q4 | $82K | Sell |
92,656
-3,851
| -4% | -$3.41K | ﹤0.01% | 3829 |
|
|
2022
Q3 | $152K | Sell |
96,507
-481
| -0.5% | -$758 | ﹤0.01% | 3745 |
|
|
2022
Q2 | $195K | Buy |
96,988
+21,397
| +28% | +$43K | ﹤0.01% | 3689 |
|
|
2022
Q1 | $176K | Sell |
75,591
-4,410
| -6% | -$10.3K | ﹤0.01% | 3776 |
|
|
2021
Q4 | $372K | Sell |
80,001
-13,823
| -15% | -$64.3K | ﹤0.01% | 3605 |
|
|
2021
Q3 | $716K | Buy |
93,824
+363
| +0.4% | +$2.77K | ﹤0.01% | 3283 |
|
|
2021
Q2 | $881K | Buy |
93,461
+11,895
| +15% | +$112K | ﹤0.01% | 3267 |
|
|
2021
Q1 | $674K | Buy |
81,566
+9,885
| +14% | +$81.7K | ﹤0.01% | 3294 |
|
|
2020
Q4 | $489K | Sell |
71,681
-8,400
| -10% | -$57.3K | ﹤0.01% | 3349 |
|
|
2020
Q3 | $893K | Buy |
80,081
+15,400
| +24% | +$172K | ﹤0.01% | 3016 |
|
|
2020
Q2 | $406K | Buy |
64,681
+5
| +0% | +$31 | ﹤0.01% | 3263 |
|
|
2020
Q1 | $119K | Buy |
+64,676
| New | +$119K | ﹤0.01% | 3519 |
|
|
2019
Q3 | – | Sell |
-12,580
| Closed | -$34K | – | 3773 |
|
|
2019
Q2 | $34K | Sell |
12,580
-90
| -0.7% | -$243 | ﹤0.01% | 3676 |
|
|
2019
Q1 | $60K | Sell |
12,670
-310
| -2% | -$1.47K | ﹤0.01% | 3631 |
|
|
2018
Q4 | $31K | Sell |
12,980
-6,350
| -33% | -$15.2K | ﹤0.01% | 3575 |
|
|
2018
Q3 | $85K | Sell |
19,330
-200
| -1% | -$879 | ﹤0.01% | 3627 |
|
|
2018
Q2 | $141K | Buy |
+19,530
| New | +$141K | ﹤0.01% | 3527 |
|
|
2015
Q3 | – | Sell |
-102,301
| Closed | -$1.8M | – | 3932 |
|
|
2015
Q2 | $1.8M | Buy |
+102,301
| New | +$1.8M | ﹤0.01% | 2807 |
|